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Abstract
Background: The population incidence of coronary heart disease (CHD) has been declining in Australia and many
other countries. This decline has been due to reduced population levels of risk factors for CHD and improved
medical care for those at higher risk of CHD. However, there are signs that there may be a slowing down or even
reversal in the decline of CHD incidence due to the ‘obesity epidemic’ and other factors and this will have
implications for the requirements for surgical treatments for those with CHD.
Methods: Using a validated Markov simulation model applied to the population of Western Australia, different
CHD incidence trend scenarios were developed to explore the effect of changing CHD incidence on requirements
for coronary artery bypass graft (CABG) and percutaneous coronary interventions (PCI), together known as coronary
artery revascularization procedures (CARPs).
Results: The most dominant component of CHD incidence is the risk of CHD hospital admission for those with no
history of CHD and if this risk leveled off and the trends in all other risks continued unchanged, then the projected
numbers of CABGs and PCIs are only minimally changed. Further, the changes in the projected numbers remained
small even when this risk was increased by 20 percent (although it is an unlikely scenario). However, when the
other CHD incidence components that had also been declining, namely, the risk of CABG and that of CHD death
for those with no history of CHD, were also projected to level off as these were declining in 1998-2000 and the
risk of PCI for those with no history of CHD (which was already increasing) was projected to further increase by
5 percent, it had a substantial effect on the projected numbers of CARPs.
Conclusion: There needs to be dramatic changes to several CHD incidence components before it has a
substantial impact on the projected requirements for CARPs. Continued monitoring of CHD incidence and also
the mix of initial presentation of CHD incidence is required in order to understand changes to future CARP
requirements.
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The population incidence of coronary heart disease
(CHD) in Australia and many other countries has been
declining for the last two to three decades [1]. In addition
to age and gender, the incidence of CHD has been shown
to vary with levels of key risk factors such as high blood
pressure, high cholesterol, smoking and diabetes. In Aus-
tralia, although the trends in major CHD risk factors
such as blood pressure, smoking and cholesterol have
been improving and have contributed to the declining
CHD incidence, the prevalence of obesity and diabetes in
the population are increasing [2]. This is evidenced by
the fact that the prevalence of obesity in 1999-2000 was
2.5 times higher than the prevalence observed in 1980
[3]. Between 1985 and 1997, the prevalence of overweight
and obesity doubled among young Australians with obe-
sity alone trebling over the same period among young
people [4]. In 1999-2000, 19% of Australian males and
22% of females aged 25 years or over were obese and an
additional 48% of males and 30% of females were over-
weight based on measured height and weight data
through the 2000 Ausdiab study [5]. The 2005 Ausdiab
follow-up showed that since 2000 on average those aged
under 65 at baseline had an increase in weight, BMI and
weist circumference [6]. Obesity, especially abdominal
obesity, increases blood pressure and total cholesterol
levels [7-9], lowers high density level (HDL) cholesterol,
and predisposes to type 2 diabetes [10]. Although studies
of obesity as a direct risk factor for CHD have been
inconsistent [11-15] and although there has been increas-
ing use of medications to control CHD risk factors such
as high blood pressure and high cholesterol [16], the obe-
sity epidemic may soon result in a slowing down or even
reversal off recent downward trends in the incidence of
CHD [17,18].
Coronary artery bypass graft (CABG) and percuta-
neous coronary interventions (PCI), together known as
coronary artery revascularization procedures (CARPs),
are common and expensive treatments for people with
coronary heart disease. The requirements for CARPs in
a population are influenced by the incidence of CHD in
the population and the effectiveness of CARPs and med-
ical treatments. We have previously developed and vali-
dated a CHD/CARP Markov Simulation model for
analyzing and forecasting the number of CARPs in the
population of Western Australia [19,20]. We have also
used this model to explore through scenario analysis the
effect of recent advances in PCIs, namely, the introduc-
tion of drug eluting stents, on requirements of CARPs
[21]. In this paper, we describe how this model can be
used to explore the sensitivity of the requirements of
CARPs due to the changing trend in CHD incidence as
might be caused by the possible and likely effect of the
obesity epidemic.
Methods
The CHD/CARP Markov simulation model [22-24] is
based on annual risks, stratified by age, gender and
CHD/CARP history, for admission to hospital for CHD,
for a PCI, for a CABG, for CHD death and non-CHD
death. The model is applied to the cohort comprising
the population of the state of Western Australia aged 35
to 79 years at the beginning of 2001. Using linked
records for individuals in the WA Health Linked Data
system [23] together with population census data, each
member of the cohort is placed in one of several
mutually exclusive CHD/CARP history states based on
their hospital admissions history for the period 1980 to
2000: (1) a history of having a PCI but no CABG some
time in the past; (2) a history of having a CABG some
time in the past; (3) a history of having a CHD admission
but no CABG or PCI some time in the past; or (4) no
history of CHD admission, CABG and PCI in the past.
The model allows members to move from one state to
another each year according to the events they experi-
ence during the year. Within a year, the model allows for
a CHD admission without a CARP, up to two admissions
with CARPs (CABG or PCI) in addition to possible
death. The model inputs include the number of cohort
members in each CHD/CARP history state by age and
gender at baseline (2001) and the values of all event risks
for each age, gender and history state for each year of
simulation (2001 to 2010). Events are simulated for each
cohort member according to the event risks and this is
continued until the cohort member dies, reaches the
upper age cutoff (80 years), or the end of the simulation
period (2010) whichever comes first. In the context of
forecasting, population event risks for past years (1998 to
2000 in our case) are calculated and used to project
event risks for future years. A total of 100 replicate simu-
lations of the cohort are performed and the average
event number (eg CARPS) over these 100 cohort simula-
tion are used as the results of the simulation Full details
of the model and a demonstration of its use for forecast-
ing (from 1995 to 1999) have been described and dis-
cussed previously [17,18]. A schematic diagram of the
Markov model is shown in Figure 1.
Results
In the CHD/CARP model, incident CHD events are
represented by the occurrence of a CHD admission
(with or without a CARP) and CHD death (without a
prior hospitalization) for people who have no history
of CHD (ie no previous CHD admission or CARP).
Figures 2, 3, 4, 5 and 6 show the estimated event prob-
abilities relating to incident CHD events for the years
from 1990 to 2000 by age for males (similar trends are
observed for females). These show that in the period
from 1995 to 2000 all the components of incident CHD
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Page 2 of 8Figure 1 Schematic diagram for the recognised events during a cycle (year).
Figure 2 Plot for Pr(CHD|history of no CHD) by calendar year, for males with different age groups.
Figure 3 Plot for Pr(a CABG|history of no CHD) by calendar year, for males with different age groups.
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Page 3 of 8Figure 4 Plot for Pr(a PCI|history of no CHD) by calendar year, for males with different age groups.
Figure 5 Plot for Pr(CHD death|no CHD and no history of CHD) by calendar year, for males with different age groups.
Figure 6 Plot for incidence of CHD by calendar year, for males with different age groups.
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Page 4 of 8have been declining except for (first-ever) hospital
admissions in which a PCI is performed and the net
effect is that total CHD incidence (Figure 6) has been
declining. Also, these Figures show that the dominant
(largest) component of CHD incidence is the risk of a
CHD admission (without a CARP) for those with no
h i s t o r yo fC H D .F o rt h eo l d e ra g eg r o u p s ,t h i sr i s k
declined very slowly during 1995-99 and at a rate lower
than that of the period 1990-94. Thus, the rate of
decline slowed down during the second half of the per-
iod 1990-99.
To investigate the impact of changing CHD incidence
on CARPs requirements we have simulated the numbers
of CABGs and PCIs for the 2001 WA population cohort
over the period 2001 to 2010. A number of simulations
are conducted. In all simulations the model uses event
risks for 2001 to 2010 that are based on extrapolating the
estimated linear trend in event risks over the years 1998
to 2000 into the period 2001 to 2010 but with certain
CHD incident event risks modified. The modifications
of event risks are described as follows and attempt to
capture a range of possible CHD event risks relating to
leveling out of some declining CHD incident event risks
and even an increase in some CHD incidence components.
Base scenario: The linear trends observed over 1998 to
2000 in all event risks (including CHD incident events)
are assumed to continue into 2001 to 2010.
Incidence (1) scenario: The Pr (CHD |no history of
CHD) levels off while the trends in other event risks
continue.
Incidence (2) scenario: The Pr(CHD|no history of
CHD) is increased by 10% while the trends in other
risks continue.
Incidence (3) scenario: The Pr (CHD| no history of
CHD) is increased by 20% while the trends in other
risks continue.
Incidence (4) scenario: The Pr(CHD|no history of
CHD) is increased by 20%, the Pr(PCI| no history of
CHD) is increased by 5%, and Pr (CABG |no history
of CHD) and Pr(CHD death|no history of CHD) both
level off, while the trends in other event risks continue.
Table 1 shows that the total simulated numbers of
CABGs and PCIs increase by only 0.96% and decrease
by only 1.58% respectively under Incidence(1) scenario
compared to the Base scenario. This is because the risk
of CHD for those with no history of CHD declined very
slowly over the period 1998-2000, and thus when these
were modified to level off and the remaining risks were
linearly extrapolated into 2001-2010, the simulated
numbers of CABGs and PCIs did not change much
from those which were simulated under the Base sce-
nario. This table further shows that under Incidence(2)
and Incidence(3) scenarios the simulated numbers of
CABGs increase by only 2.20% and 3.39% respectively as
compared to the Base scenario. The corresponding
increases for PCIs are 4.55% and 5.3% respectively. The
change in simulated number of CABGs under Incidence
(4) scenario compared to the Base scenario is more dra-
matic as this number is 25.16% greater than that
obtained by the Base scenario. The corresponding
increase for PCIs is 18.57%.
Figure 7 shows the total projected numbers of CABGs
and PCIs obtained under the various simulation scenar-
ios by single year over 2001-2010. The differences
between the simulated numbers of CABGs and PCIs
obtained under Incidence(1) and Base scenarios are very
small for every calendar year. Similarly, the respective
differences between the simulated numbers of CABGs
and PCIs obtained under Incidence(2) and Incidence(3)
scenarios in comparison to Base scenario are small.
However, the differences between the simulated num-
bers of CABGs and PCIs obtained under Incidence(4)
and Base scenarios, are larger and generally increase
with calendar year.
Discussion and conclusions
In this study, we have used a previously validated CHD/
CARP Markov simulation model for evaluating the
effect of changing CHD incidence trends on require-
ments of CARPs. CHD incidence has been declining for
some time but this trend might level out or even reverse
due to the obesity epidemic. Recent data for obesity in
WA indicate that mean BMI has increased at the rate of
0.175 kg/m
2 per year over the period 2002-2006 [22]
which is faster than the rate of increase in mean BMI
over 1983-1999 as reported by Hobbs et al [15]. These
data support the underlying assumption for the develop-
ment of our incidence scenarios. However, other risk
Table 1 Comparison between projected numbers of CARPs (2001-2010) based on linear, incidence(1), incidence(2),
incidence(3) and incidence(4) scenarios
Total event Base scenario Modified(1)
scenario
Modified(2)
Scenario
Modified(3)
Scenario
Modified(4)
Scenario
CABG 10084 10181 10306 10426 12621
% change from linear extrapolation — 0.96 2.20 3.39 25.16
PCI 26757 26333 27975 28174 30483
% change from linear extrapolation -1.58 4.55 5.30 13.93
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ple, mean levels of cholesterol actually declined over the
same period, possibly because of a compensating
increase in personal awareness of cholesterol levels and
increased use of cholesterol lowering treatment. The net
effect on CHD incidence is unclear but it is still worth
e x p l o r i n gt h er a n g eo fp o s s i b l ee f f e c t so nC A R P
requirements.
There are a number of factors, other than population
risk factor levels, which could also influence trends for
CHD incidence in the population based on hospital
admission data. For example, a recent study in WA
demonstrated that while the long-standing decline in
hospital admission rates for MI appeared to level off
after 1997 it is likely to have been an artefact related to
more sensitive and specific biomarkers for myocardial
damage (troponins) [23]. It should also be noted that
“pre-emptive” CARPs performed in persons with sub-
acute CHD such as angina pectoris could also have
contributed to the downward trend in incident acute
CHD without CARPs such as MI or unstable angina.
CARP rates may also have been affected by broadening
of clinical indications for coronary revascularization.
For example, immediate (Primary) PCI is now the pre-
ferred method of coronary artery revascularization in
acute coronary syndromes (MI or unstable angina) in
place of thrombolytic (medical) treatment. There
would thus be an apparent decrease in incident CHD
without CARP and a reciprocal increase in CARP with
CHD.
The requirements for CARPs may also be influenced
by the changing trends in diabetes prevalence. In WA,
the prevalence of diabetes has been increasing. However,
one of the principal drivers for this change could very
well be the obesity epidemic in the population. Thus,
this again reiterates the indirect effect the obesity epi-
demic may have on the future requirements of CARPs.
In our study, we have developed four incidence sce-
narios in such a way that they represented a gradual
deterioration in the favourable CHD incidence trends
and assumed that other risks continued in their current
trend pattern. The strategy adopted for developing the
scenarios was that the most dominant component of
CHD incidence was first gradually altered and finally the
remaining components were altered. The results showed
that if the most dominant component of CHD inci-
dence, that is, the risk of CHD admission for those with
no history of CHD levelled off and the trends in all
other transition probabilities continued, then the pro-
jected numbers of CABGs and PCIs for 2001-2010 were
insensitive to these changes. Even in the unlikely sce-
nario of increasing this event probability by 20% did not
alter the results much. However, when the other com-
ponents of CHD incidence, namely risk of CABG for
those with no history of CHD, risk of PCI for those
with no history of CHD and risk of CHD death for
those with no history of CHD, were projected to
increase from the baseline period of 1998-2000 to 2001-
2010, the requirements of CARPs increased substan-
tially. Thus, this scenario analysis suggests that if there
is increased CHD incidence involving an increased like-
lihood of a CARP in a person’s first ever CHD hospital
admission then there may be a substantial increase in
the requirements of CARPs and hence a substantial
increase in costs for managing CHD. However, if the
increase involves more PCIs rather than CABGs then
the increased cost burden may be less given the relative
cost of the two procedures [24].
A limitation of this study is that it was initiated in
2004 when the complete collection of state-wide data
was available up to 2000. Hence the model based esti-
mates and trends applied to the period 1998 to 2000
and these were used to project the number of PCI
and CABG in Western Australia over the period of
Figure 7 Comparison between projected numbers of CABGs and PCIs by base, incidence(1), incidence(2), incidence(3) and incidence(4)
scenarios over the period 2001-2010.
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of CARP forecasts to various scenarios relating to chan-
ging CHD incidence are still broadly applicable and
highlight the need to not only monitor the changing
CHD incidence due to the obesity epidemic and rising
prevalence of diabetes but also the need to examine the
changing nature of initial presentation of CHD, that is a
first-ever CHD hospital admission with or without a
CARP.
A limitation of our study for investigating the effect of
changes in risk factor trends on CARP requirements is
that it does not directly incorporate population risk fac-
tor levels. Theoretically, it is possible to directly incor-
porate population risk factor data into the CHD/CARP
model. Risk factor prevalence data from population
surveys could be used to divide the population without
history of CHD into risk factor strata and Framingham-
type equations for projecting CHD incidence rather
than the risk estimates for incident CHD used in the
present study. In other words, we could replace the inci-
dence risks by a separate incidence submodel similar to
what the CHD Policy Model [25] does. However, to
know the relative importance of CHD risk factors at the
population level and to record changes in these factors
over time requires person-based information about
long-term trends in these factors and these data need to
be linked longitudinally to relevant outcomes in the
same individuals. Such data are not available at the
population level in WA and in most populations.
In this study, we have presented only one particular
use of the WA CHD/CARP Markov simulation model.
As discussed earlier this model has already been used to
explore scenarios evaluating the effect of advances in
PCI on future requirements of CARPs [21]. However, a
number of other applications remain to be explored.
These include but are not limited to determining the
effect on requirements of CARPs of advances in medical
treatments related to CHD and changes in health policy
related to treating CHD patients. Examples of determin-
ing effects of advances in medical treatments include
increasing use of prescribed aspirin, lipid lowering
drugs, statins and ACE inhibitors. Examples of examin-
ing effects on requirements of CARPs due to changes in
health policy include change in health policy (by the
Australian government) regarding subsidising statins by
only providing subsidy to people at higher risk of CHD.
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